FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> FDA   Phase III   GlaxoSmithKline   Europe
Syndicate content

EMEA News

Most Popular EMEA Story

EMEA shoots down UBC's Cimzia

It looks like UBC has struck out in the EU. The EMEA told the company that the Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion on Cimzia, a treatment for Crohn's Read more...

Latest Headlines